Mr. Jonathan Robinson reports
VENTRIPOINT DIAGNOSTICS REPORTS RESULTS OF ANNUAL GENERAL & SPECIAL SHAREHOLDERS MEETING
Ventripoint Diagnostics Ltd. has released the results of its annual general and special meeting of shareholders held on Nov. 1, 2023, in Toronto. Shareholders voted in favour of each of the matters considered at the Meeting, including electing each of Dr. George Adams, Robert Hodgkinson, Hugh MacNaught,
Fiona Fitzgerald, Randy AuCoin, and Dr. Alvira Macanovic as directors of the Company to hold office for the ensuing year, appointing MNP LLP as the Company's auditors for the ensuing year, authorizing the board of directors to set their remuneration, and re-approving the Company's stock option plan, all as described in the Company's Information Circular dated October 2, 2023.
The CEO
slide presentation and transcript
are available on the
Ventripoint website at: https://www.ventripoint.com/annual-meeting.
About Ventripoint
Diagnostics Ltd.
Ventripoint
has
become
an
industry
leader
in
the
application
of
AI
(Artificial
Intelligence)
to
echocardiography.
Ventripoint's
VMS
products
are
powered
by
its
proprietary
KBR
technology,
which
is
the
result
of
a
decade
of
development
and
provides
accurate
volumetric
cardiac
measurements
equivalent
to
MRI.
This
affordable,
gold-standard
alternative
allows
cardiologists
greater
confidence
in
the
management
of
their
patients.
Providing
better
care
to
patients
serves
as
a
springboard
and
basic
standard
for
all
of
Ventripoint's
products
that
guide
our
future
developments.
In
addition,
VMS+
is
versatile
and
can
be
used
with
all
ultrasound
systems
from
any
vendor
supported
by
regulatory
market
approvals in
the
U.S.,
Europe,
and
Canada.
For further
information,
please contact:
Jonathan Robinson
JRobinson@oakhillfinancial.ca
416-669-1001
Neither the TSX Venture
Exchange
nor
its Regulation Services Provider (as that term
is
defined in
the
policies
of the TSX Venture
Exchange) accepts responsibility for the adequacy or
accuracy of this
news release.
Copyright (c) 2023 TheNewswire - All rights reserved.
© 2024 Canjex Publishing Ltd. All rights reserved.